Anne Dormoy

1.1k total citations
30 papers, 547 citations indexed

About

Anne Dormoy is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Anne Dormoy has authored 30 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 9 papers in Hematology and 6 papers in Genetics. Recurrent topics in Anne Dormoy's work include T-cell and B-cell Immunology (21 papers), Immune Cell Function and Interaction (13 papers) and Immunotherapy and Immune Responses (7 papers). Anne Dormoy is often cited by papers focused on T-cell and B-cell Immunology (21 papers), Immune Cell Function and Interaction (13 papers) and Immunotherapy and Immune Responses (7 papers). Anne Dormoy collaborates with scholars based in France, Netherlands and Germany. Anne Dormoy's co-authors include Jean‐Pierre Cazenave, Hans Ulrich Weltzien, Corinne Moulon, Jürgen Vollmer, M. Fritz, Marie‐Marthe Tongio, Daniel Hanau, Dominique Fricker, Jacques Zimmer and Catherine Angénieux and has published in prestigious journals such as Journal of Clinical Investigation, European Journal of Immunology and Journal of Investigative Dermatology.

In The Last Decade

Anne Dormoy

30 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Dormoy France 11 383 78 66 63 59 30 547
Erxia Shen China 12 403 1.1× 64 0.8× 63 1.0× 35 0.6× 131 2.2× 25 568
Magali de Heusch Belgium 11 559 1.5× 22 0.3× 140 2.1× 62 1.0× 86 1.5× 15 674
Akiko Oyamada Japan 11 305 0.8× 32 0.4× 13 0.2× 97 1.5× 81 1.4× 17 504
H Borel United States 9 217 0.6× 76 1.0× 16 0.2× 66 1.0× 17 0.3× 20 382
Liduine A. van den Bersselaar Netherlands 8 175 0.5× 23 0.3× 16 0.2× 40 0.6× 64 1.1× 8 513
Jared Velasco Australia 4 325 0.8× 167 2.1× 72 1.1× 34 0.5× 18 0.3× 8 524
Ren Zhu France 9 668 1.7× 45 0.6× 15 0.2× 81 1.3× 92 1.6× 15 853
Christoffer Dellgren Denmark 6 207 0.5× 24 0.3× 178 2.7× 102 1.6× 89 1.5× 11 555
Susanne Rohrer Switzerland 7 198 0.5× 108 1.4× 24 0.4× 33 0.5× 21 0.4× 13 365
Odile Avinens France 9 225 0.6× 33 0.4× 10 0.2× 58 0.9× 37 0.6× 10 381

Countries citing papers authored by Anne Dormoy

Since Specialization
Citations

This map shows the geographic impact of Anne Dormoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Dormoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Dormoy more than expected).

Fields of papers citing papers by Anne Dormoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Dormoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Dormoy. The network helps show where Anne Dormoy may publish in the future.

Co-authorship network of co-authors of Anne Dormoy

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Dormoy. A scholar is included among the top collaborators of Anne Dormoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Dormoy. Anne Dormoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daguindau, Étienne, Marylise Fort, Sophie Caillat‐Zucman, et al.. (2025). HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation. HemaSphere. 9(2). e70088–e70088. 1 indexed citations
2.
Laheurte, Caroline, Jeanne Galaine, Magalie Dosset, et al.. (2016). Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4+Th1 responses against telomerase in cancer patients. OncoImmunology. 5(5). e1137416–e1137416. 18 indexed citations
3.
Laheurte, Caroline, Jeanne Galaine, Magalie Dosset, et al.. (2016). Immunoprevalence and magnitude of HLA-DP versus HLA-DR-restricted spontaneous CD4 Th1 responses against telomerase in cancer patients. Faculty of 1000 Research Ltd. 5. 2 indexed citations
4.
Gagne, Katia, Marc Busson, Jean‐Denis Bignon, et al.. (2009). Donor KIR3DL1/3DS1 Gene and Recipient Bw4 KIR Ligand as Prognostic Markers for Outcome in Unrelated Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 15(11). 1366–1375. 34 indexed citations
5.
Gagne, Katia, Marc Busson, Léna Absi, et al.. (2007). Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations. Tissue Antigens. 69(s1). 118–122. 10 indexed citations
6.
Perrier, Pascal, et al.. (2007). HLA‐B*0749N: the first HLA‐B*07 null allele. Tissue Antigens. 70(4). 341–343. 1 indexed citations
7.
Malkki, Mari, Ted Gooley, Mary M. Horowitz, et al.. (2007). Mapping MHC-Resident Transplantation Determinants. Biology of Blood and Marrow Transplantation. 13(8). 986–995. 10 indexed citations
8.
Reinders, Judith, Erik H. Rozemuller, Henny G. Otten, et al.. (2005). Identification of HLA-A*0111N: A Synonymous Substitution, Introducing an Alternative Splice Site in Exon 3, Silenced the Expression of an HLA-A Allele. Human Immunology. 66(8). 912–920. 24 indexed citations
10.
Dormoy, Anne, et al.. (2002). Second HLA‐A*68 null allele, A*6818 N, identified. Tissue Antigens. 60(1). 88–90. 5 indexed citations
11.
Dormoy, Anne, Daniel Hanau, M. M. Tongio, & Jean‐Pierre Cazenave. (2000). Development and validation of a genotyping kit for the eight principal human platelet alloantigen systems. Transfusion Clinique et Biologique. 7(1). 51–62. 9 indexed citations
12.
Vollmer, Jürgen, Hans Ulrich Weltzien, Anne Dormoy, F.H.M. Pistoor, & Corinne Moulon. (1999). Functional Expression and Analysis of a Human HLA-DQ Restricted, Nickel-Reactive T Cell Receptor in Mouse Hybridoma Cells. Journal of Investigative Dermatology. 113(2). 175–181. 18 indexed citations
14.
Vollmer, Jürgen, M. Fritz, Anne Dormoy, Hans Ulrich Weltzien, & Corinne Moulon. (1997). Dominance of the BV17 element in nickel‐specific human T cell receptors relates to severity of contact sensitivity. European Journal of Immunology. 27(8). 1865–1874. 59 indexed citations
15.
Dormoy, Anne, et al.. (1996). A newHLA-DRB1 * 13 allele (DRB1 * 1318) with a shortDRB1*08 sequence. Immunogenetics. 43(4). 240–241. 3 indexed citations
16.
Perrier, Pascal & Anne Dormoy. (1996). A new DPB1 allele (DPB1*5901) identified by reverse dot blot hybridization and confirmed by DNA sequencing. Tissue Antigens. 47(4). 356–359. 2 indexed citations
17.
Dormoy, Anne, A. Urlacher, & Marie‐Marthe Tongio. (1992). Complexity of the HLA-DP region: RFLP analysis versus PLT typing and oligotyping. Human Immunology. 34(1). 39–46. 7 indexed citations
18.
Urlacher, A., Anne Dormoy, & M. M. Tongio. (1992). DP epitope mapping by using T-cell clones. Human Immunology. 35(2). 100–108. 8 indexed citations
19.
Tongio, M. M., et al.. (1991). The third subset of HLA‐A9*. Tissue Antigens. 37(5). 235–236. 5 indexed citations
20.
Mitsuishi, Y., et al.. (1989). Routine HLA-DP typing by RFLP analysis.. PubMed. 31(6). 387–92. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026